Back


05/07/2017
Matthew Gantz Appointed CEO of Oxthera
OxThera AB, a Stockholm-based privately-held biopharmaceutical company today announced the appointment of Matthew Gantz as their new CEO. He succeeds Elisabeth Lindner as CEO, who will continue as COO of Oxthera overseeing the Oxabact program. [...]

Download the pdf file





X

X